Prodromal symptoms and early intervention to prevent a relapse.
Completed
- Registration Number
- NL-OMON20905
- Lead Sponsor
- Department of Psychotic DisordersMental Health Care Services DrenthePO Box 30.0079400 RA Assendrs J Arends Tel +31 (0)592 334883Johan.Arends@GGZDrenthe.nl
- Brief Summary
Relapse Prevention in Schizophrenia: a randomised controlled trial between self-Monitoring and Training with the symptom management module, and a comparison with Treatment As Usual (submitted).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 147
Inclusion Criteria
1. ICD-10 diagnosis of schizophrenia (F20) or schizoaffective disorder (F25);
Exclusion Criteria
Substance abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurence of a psychotic relapse: a worsening of at least two points on the CGI as assessed by psychiatrist and verified by researcher by a PANSS-interview within a week.
- Secondary Outcome Measures
Name Time Method 1. Hospiatlisation; <br /><br>2. Psychopathology.